Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Feb;29(2):185–187. doi: 10.1128/aac.29.2.185

Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets.

L J Goodman, R L Kaplan, R M Petrak, R M Fliegelman, D Taff, F Walton, J L Penner, G M Trenholme
PMCID: PMC176374  PMID: 2940963

Abstract

Ciprofloxacin was compared with erythromycin for the eradication of Campylobacter species that were chronically excreted in the stools of marmosets (Saguinus labiatus labiatus, Saguinus fuscicollis nigrifrons, and Saguinus fuscicollis illigeri). Stool cultures were negative within 48 h of the beginning of treatment with either agent. Within 10 days after the end of therapy, however, Campylobacter species were again isolated from the stools of six animals that had received erythromycin. During an 8-week follow-up period, no animal that had received ciprofloxacin relapsed. High levels of ciprofloxacin in the stool (mean, 49.2 micrograms/g) possibly contributed to the efficacy of this agent.

Full text

PDF
185

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crump B., Wise R., Dent J. Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother. 1983 Nov;24(5):784–786. doi: 10.1128/aac.24.5.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fliegelman R. M., Petrak R. M., Goodman L. J., Segreti J., Trenholme G. M., Kaplan R. L. Comparative in vitro activities of twelve antimicrobial agents against Campylobacter species. Antimicrob Agents Chemother. 1985 Mar;27(3):429–430. doi: 10.1128/aac.27.3.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Goodman L. J., Fliegelman R. M., Trenholme G. M., Kaplan R. L. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrob Agents Chemother. 1984 Apr;25(4):504–506. doi: 10.1128/aac.25.4.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hartley C. L., Clements H. M., Linton K. B. Effects of cephalexin, erythromycin and clindamycin on the aerobic Gram-negative faecal flora in man. J Med Microbiol. 1978 May;11(2):125–135. doi: 10.1099/00222615-11-2-125. [DOI] [PubMed] [Google Scholar]
  5. Hwang M. N., Ederer G. M. Rapid hippurate hydrolysis method for presumptive identification of group B streptococci. J Clin Microbiol. 1975 Jan;1(1):114–115. doi: 10.1128/jcm.1.1.114-115.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kiehlbauch J. A., Albach R. A., Baum L. L., Chang K. P. Phagocytosis of Campylobacter jejuni and its intracellular survival in mononuclear phagocytes. Infect Immun. 1985 May;48(2):446–451. doi: 10.1128/iai.48.2.446-451.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Nichols R. L., Condon R. E., DiSanto A. R. Preoperative bowel preparation. Erythromycin base serum and fecal levels following oral administration. Arch Surg. 1977 Dec;112(12):1493–1496. doi: 10.1001/archsurg.1977.01370120083010. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES